107. Juvenile idiopathic arthritis Clinical trials / Disease details

Clinical trials : 441 / Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142

27 trials found

diseases per page:

Showing 1 to 10 of 27 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-002018-29-HU (EUCTR)	04/01/2022	25/10/2021	Efficacy and Safety Study Of Tofacitinib in Pediatric sJIA Population	EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENIL ...	Systemic Juvenile Idiopathic Arthritis (sJIA);Therapeutic area: Diseases [C] - Immune System Disease ...	Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: tofacitinib Other des ...	Pfizer Inc. 235 East 42nd Street, New York, New York 10017	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 3	United States;Slovakia;Spain;Costa Rica;Ukraine;Turkey;Israel;Russian Federation;United Kingdom;Ital ...
2	EUCTR2017-002018-29-NL (EUCTR)	19/10/2021	10/12/2020	Efficacy and Safety Study Of Tofacitinib in Pediatric sJIA Population	EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENIL ...	Systemic Juvenile Idiopathic Arthritis (sJIA);Therapeutic area: Diseases [C] - Immune System Disease ...	Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: tofacitinib Other des ...	Pfizer Inc. 235 East 42nd Street, New York, New York 10017	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 3	United States;Slovakia;Spain;Costa Rica;Ukraine;Turkey;Russian Federation;Israel;United Kingdom;Ital ...
3	EUCTR2017-002018-29-DE (EUCTR)	02/02/2021	23/09/2020	Efficacy and Safety Study Of Tofacitinib in Pediatric sJIA Population	EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENIL ...	Systemic Juvenile Idiopathic Arthritis (sJIA);Therapeutic area: Diseases [C] - Immune System Disease ...	Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: tofacitinib Other des ...	Pfizer Inc. 235 East 42nd Street, New York, New York 10017	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 3	United States;Slovakia;Spain;Ukraine;Turkey;Chile;Israel;Russian Federation;United Kingdom;Italy;Ind ...
4	EUCTR2017-002018-29-SK (EUCTR)	09/12/2020	04/08/2020	Efficacy and Safety Study Of Tofacitinib in Pediatric sJIA Population	EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENIL ...	Systemic Juvenile Idiopathic Arthritis (sJIA) MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: tofacitinib Other des ...	Pfizer Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 3	United States;Slovakia;Spain;Costa Rica;Ukraine;Turkey;Russian Federation;Israel;United Kingdom;Ital ...
5	EUCTR2017-002018-29-PL (EUCTR)	28/10/2020	09/08/2020	Efficacy and Safety Study Of Tofacitinib in Pediatric sJIA Population	EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENIL ...	Systemic Juvenile Idiopathic Arthritis (sJIA);Therapeutic area: Diseases [C] - Immune System Disease ...	Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: tofacitinib Other des ...	Pfizer Inc. 235 East 42nd Street, New York, New York 10017	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 3	United States;Slovakia;Spain;Costa Rica;Ukraine;Turkey;Israel;Russian Federation;United Kingdom;Ital ...
6	EUCTR2015-001438-46-PL (EUCTR)	16/04/2019	30/01/2018	Efficacy Study Of Tofacitinib In Pediatric JIA Population	EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIO ...	JUVENILE IDIOPATHIC ARTHRITIS (JIA) MedDRA version: 20.0;Level: PT;Classification code 10059176;Term ...	Trade Name: XELJANZ Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: t ...	Pfizer Inc, 235 East 42nd Street, New York, New York 10017	NULL	Not Recruiting			Female: yes Male: yes	210	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Spain;Ukraine;Turkey;Russian Federation;Israel;Chile;Switzerland;United Kingdom;Mexico ...
7	EUCTR2015-001438-46-DE (EUCTR)	16/04/2018	13/12/2017	Efficacy Study Of Tofacitinib In Pediatric JIA Population	EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FORTREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOP ...	JUVENILE IDIOPATHIC ARTHRITIS (JIA) MedDRA version: 20.0;Level: PT;Classification code 10059176;Term ...	Trade Name: XELJANZ Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: t ...	Pfizer Inc, 235 East 42nd Street, New York, New York 10017	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 3	United States;Spain;Ukraine;Turkey;Russian Federation;Israel;Chile;Switzerland;United Kingdom;Mexico ...
8	EUCTR2015-001438-46-ES (EUCTR)	05/04/2018	21/12/2017	Efficacy Study Of Tofacitinib In Pediatric JIA Population	EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIO ...	JUVENILE IDIOPATHIC ARTHRITIS (JIA) MedDRA version: 20.0;Level: PT;Classification code 10059176;Term ...	Trade Name: XELJANZ Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: t ...	Pfizer Inc, 235 East 42nd Street, New York, New York 10017	NULL	Not Recruiting			Female: yes Male: yes	210	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Germany;South Africa;Australia;Brazil;Belgium;Poland;Argentina;Canada;Mexico;United Kingdom;Switzerl ...
9	EUCTR2011-004915-22-GB (EUCTR)	03/04/2018	21/12/2017	A Long-Term, Open-Label, Study for Treatment of JIA	A LONG-TERM, OPEN-LABEL FOLLOW-UP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITI ...	JUVENILE IDIOPATHIC ARTHRITIS (JIA) MedDRA version: 21.0;Level: PT;Classification code 10059176;Term ...	Trade Name: XELJANZ Product Code: CP -690,550-10 INN or Proposed INN: Tofacitinib Product Code: CP -690,5 ...	Pfizer Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	340	Phase 2;Phase 3	New Zealand;Germany;Poland;Belgium;Brazil;Argentina;Canada;Mexico;Hungary;United Kingdom;Turkey;Sout ...
10	EUCTR2015-001438-46-GB (EUCTR)	27/03/2018	28/11/2017	Efficacy Study Of Tofacitinib In Pediatric JIA Population	EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FORTREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOP ...	JUVENILE IDIOPATHIC ARTHRITIS (JIA) MedDRA version: 20.0;Level: PT;Classification code 10059176;Term ...	Trade Name: XELJANZ Product Name: Tofacitinib citrate Product Code: CP -690,550-10 INN or Proposed INN: t ...	Pfizer Inc.	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 3	United States;Spain;Ukraine;Turkey;Chile;Israel;Russian Federation;Switzerland;United Kingdom;Mexico ...

First Previous1 2 3Next Last